Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LUS and IVC vs PPV for Fluid Responsiveness in Critically Ill Patients
NCT05980494Completed
- Sponsor
- Fayoum University Hospital
- Start
- Sep 2022
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Fayoum University Hospital. Primary endpoint: Sensitivity of lung ultrasound in predicting fluid responsiveness. Started Sep 2022; status: completed.
Beyond the preview
Go deeper on NCT05980494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05980494.